{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:22:06Z","timestamp":1790832126054,"version":"4.1.0"},"reference-count":150,"publisher":"e-Century Publishing Corporation","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/rtgf8675","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T08:26:39Z","timestamp":1762763199000},"page":"8222-8242","source":"Crossref","is-referenced-by-count":1,"title":["The role of regulatory T cells in central nervous system diseases in dogs: fighting with a double-edged sword toward translational discoveries"],"prefix":"10.62347","volume":"17","author":[{"given":"Estefania D","family":"Benavides","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","article-title":"The global burden of neurological disorders: translating evidence into policy","volume":"19","author":"Feigin","year":"2019","unstructured":"Feigin VL, Vos T, Nichols E, Owolabi MO, Carroll WM, Dichgans M, Deuschl G, Parmar P, Brainin M and Murray C. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol 2019; 19: 255-265.","journal-title":"Lancet Neurol"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Grech N, Dalli T, Mizzi S, Meilak L, Calleja N and Zrinzo A. Rising incidence of glioblastoma multiforme in a well-defined population. Cureus 2020; 12: e8195.","DOI":"10.7759\/cureus.8195"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, Robertson N, Rocca NL, Uitdehaag B, Mei I van der, Wallin M, Helme A, Napier CA, Rijke N and Baneke P. Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler 2020; 26: 1816-1821.","journal-title":"Mult Scler"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Tizard I. Chapter 7 - Autoimmune Neurologic Diseases. In: Tizard I, editor. Autoimmune Diseases in Domestic Animals. New Delhi: Elsevier; 2023. p. 77-94.","DOI":"10.1016\/B978-0-323-84813-8.00007-6"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1084\/jem.20180199","article-title":"Immune cells and CNS physiology: microglia and beyond","volume":"216","author":"Norris","year":"2019","unstructured":"Norris GT and Kipnis J. Immune cells and CNS physiology: microglia and beyond. J Exp Med 2019; 216: 60-70.","journal-title":"J Exp Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0301-0082(02)00010-2","article-title":"Involvement of inflammatory cytokines in central nervous system injury","volume":"67","author":"Wang","year":"2002","unstructured":"Wang CX and Shuaib A. Involvement of inflammatory cytokines in central nervous system injury. Prog Neurobiol 2002; 67: 161-172.","journal-title":"Prog Neurobiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.neuroscience.2008.09.009","article-title":"Neuro-immune crosstalk in CNS diseases","volume":"158","author":"Kerschensteiner","year":"2009","unstructured":"Kerschensteiner M, Meinl E and Hohlfeld R. Neuro-immune crosstalk in CNS diseases. Neuroscience 2009; 158: 1122-1132.","journal-title":"Neuroscience"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/jnr.24073","article-title":"The role of regulatory T cells in nervous system pathologies","volume":"96","author":"Duffy","year":"2018","unstructured":"Duffy SS, Keating BA, Perera CJ and Moalem-Taylor G. The role of regulatory T cells in nervous system pathologies. J Neurosci Res 2018; 96: 951-968.","journal-title":"J Neurosci Res"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T and Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133: 775-787.","journal-title":"Cell"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.14712\/18059694.2016.63","article-title":"Regulatory T cells (Treg) and their roles in immune system with respect to immunopathological disorders","volume":"53","author":"Kond&#x11B","year":"2010","unstructured":"Kond&#x11B;lkov&#xE1; K, Vokurkov&#xE1; D, Krejsek J, Borsk&#xE1; L, Fiala Z and Andr&#xFD;s C. Regulatory T cells (Treg) and their roles in immune system with respect to immunopathological disorders. Acta Medica (Hradec Kralove) 2010; 53: 73-77.","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/cei\/uxac084","article-title":"The potential for treg-enhancing therapies in nervous system pathologies","volume":"211","author":"KE","year":"2023","unstructured":"Olson KE, Mosley RL and Gendelman HE. The potential for treg-enhancing therapies in nervous system pathologies. Clin Exp Immunol 2023; 211: 108-121.","journal-title":"Clin Exp Immunol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.nec.2009.08.012","article-title":"The role of tregs in glioma-mediated immunosuppression: potential target for intervention","volume":"21","author":"Humphries","year":"2010","unstructured":"Humphries W, Wei J, Sampson JH and Heimberger AB. The role of tregs in glioma-mediated immunosuppression: potential target for intervention. Neurosurg Clin N Am 2010; 21: 125-137.","journal-title":"Neurosurg Clin N Am"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jneuroim.2010.05.020","article-title":"Prognostic significance and mechanism of Treg infiltration in human brain tumors","volume":"225","author":"Jacobs","year":"2010","unstructured":"Jacobs JF, Idema AJ, Bol KF, Grotenhuis JA, de Vries IJ, Wesseling P and Adema GJ. Prognostic significance and mechanism of Treg infiltration in human brain tumors. J Neuroimmunol 2010; 225: 195-199.","journal-title":"J Neuroimmunol"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Heimberger AB, Kong LY, Abou-Ghazal M, Reina-Ortiz C, Yang DS, Wei J, Qiao W, Schmittling RJ, Archer GE, Sampson JH, Hiraoka N, Priebe W, Fuller GN and Sawaya R. The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor. Clin Neurosurg 2009; 56: 98-106.","DOI":"10.1227\/01.NEU.0000333524.54656.42"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00262-019-02317-9","article-title":"Absolute numbers of regulatory T cells and neutrophils in corticosteroid-free patients are predictive for response to bevacizumab in recurrent glioblastoma patients","volume":"68","author":"Quillien","year":"2019","unstructured":"Quillien V, Carpentier AF, Gey A, Avril T, Tartour E, Sejalon F, Campillo-Gimenez B and Vauleon E. Absolute numbers of regulatory T cells and neutrophils in corticosteroid-free patients are predictive for response to bevacizumab in recurrent glioblastoma patients. Cancer Immunol Immunother 2019; 68: 871-882.","journal-title":"Cancer Immunol Immunother"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s41598-020-80567-9","article-title":"Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation","volume":"11","author":"L&#xF3","year":"2021","unstructured":"L&#xF3;pez-Abente J, Mart&#xED;nez-Bonet M, Bernaldo-de-Quir&#xF3;s E, Camino M, Gil N, Panadero E, Gil-Jaurena JM, Clemente M, Urschel S, West L, Pion M and Correa-Rocha R. Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation. Sci Rep 2021; 11: 827.","journal-title":"Sci Rep"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/cas.13889","article-title":"Persistent restoration to the immunosupportive tumor microenvironment in glioblastoma by bevacizumab","volume":"110","author":"Tamura","year":"2019","unstructured":"Tamura R, Tanaka T, Ohara K, Miyake K, Morimoto Y, Yamamoto Y, Kanai R, Akasaki Y, Murayama Y, Tamiya T, Yoshida K and Sasaki H. Persistent restoration to the immunosupportive tumor microenvironment in glioblastoma by bevacizumab. Cancer Sci 2019; 110: 499-508.","journal-title":"Cancer Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1158\/0008-5472.CAN-19-1577","article-title":"Dysregulation of glutamate transport enhances treg function that promotes VEGF blockade resistance in glioblastoma","volume":"80","author":"Long","year":"2020","unstructured":"Long Y, Tao H, Karachi A, Grippin AJ, Jin L, Chang YE, Zhang W, Dyson KA, Hou AY, Na M, Deleyrolle LP, Sayour EJ, Rahman M, Mitchell DA, Lin Z and Huang J. Dysregulation of glutamate transport enhances treg function that promotes VEGF blockade resistance in glioblastoma. Cancer Res 2020; 80: 499-509.","journal-title":"Cancer Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/neuonc\/noab118","article-title":"Activity of PD-1 blockade with nivolumab among patients with recurrent atypical\/anaplastic meningioma: phase II trial results","volume":"24","author":"WL","year":"2022","unstructured":"Bi WL, Nayak L, Meredith DM, Driver J, Du Z, Hoffman S, Li Y, Lee EQ, Beroukhim R, Rinne M, McFaline-Figueroa R, Chukwueke U, McCluskey C, Gaffey S, Cherniack AD, Stefanik J, Doherty L, Taubert C, Cifrino M, LaFrankie D, Graillon T, Wen PY, Ligon KL, Al-Mefty O, Huang RY, Muzikansky A, Chiocca EA, Santagata S, Dunn IF and Reardon DA. Activity of PD-1 blockade with nivolumab among patients with recurrent atypical\/anaplastic meningioma: phase II trial results. Neuro Oncol 2022; 24: 101-113.","journal-title":"Neuro Oncol"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"DiDomenico J, Lamano JB, Oyon D, Li Y, Veliceasa D, Kaur G, Ampie L, Choy W, Lamano JB and Bloch O. The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma. Oncoimmunology 2018; 7: e1448329.","DOI":"10.1080\/2162402X.2018.1448329"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"874","DOI":"10.2174\/1570159X14666161208151525","article-title":"From leflunomide to teriflunomide: drug development and immunosuppressive oral drugs in the treatment of multiple sclerosis","volume":"15","author":"Aly","year":"2017","unstructured":"Aly L, Hemmer B and Korn T. From leflunomide to teriflunomide: drug development and immunosuppressive oral drugs in the treatment of multiple sclerosis. Curr Neuropharmacol 2017; 15: 874-891.","journal-title":"Curr Neuropharmacol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"104719","DOI":"10.1016\/j.msard.2023.104719","article-title":"Teriflunomide modulates both innate and adaptive immune capacities in multiple sclerosis","volume":"75","author":"Wu","year":"2023","unstructured":"Wu Q, Wang Q, Yang J, Mills EA, Chilukuri P, Saad A, Dowling CA, Fisher C, Kirch B and Mao-Draayer Y. Teriflunomide modulates both innate and adaptive immune capacities in multiple sclerosis. Mult Scler Relat Disord 2023; 75: 104719.","journal-title":"Mult Scler Relat Disord"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.3390\/cells9061396","article-title":"The meaning of immune reconstitution after alemtuzumab therapy in multiple sclerosis","volume":"9","author":"Rolla","year":"2020","unstructured":"Rolla S, Maglione A, De Mercanti SF and Clerico M. The meaning of immune reconstitution after alemtuzumab therapy in multiple sclerosis. Cells 2020; 9: 1396.","journal-title":"Cells"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1000152","DOI":"10.4172\/2155-9899.1000152","article-title":"Insights into the mechanisms of the therapeutic efficacy of alemtuzumab in multiple sclerosis","volume":"4","author":"Freedman","year":"2013","unstructured":"Freedman MS, Kaplan JM and Markovic-Plese S. Insights into the mechanisms of the therapeutic efficacy of alemtuzumab in multiple sclerosis. J Clin Cell Immunol 2013; 4: 1000152.","journal-title":"J Clin Cell Immunol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1002\/eji.200535075","article-title":"Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis","volume":"35","author":"Cox","year":"2005","unstructured":"Cox AL, Thompson SA, Jones JL, Robertson VH, Hale G, Waldmann H, Compston DA and Coles AJ. Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis. Eur J Immunol 2005; 35: 3332-3342.","journal-title":"Eur J Immunol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"20200","DOI":"10.1073\/pnas.1313654110","article-title":"Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation","volume":"110","author":"Jones","year":"2013","unstructured":"Jones JL, Thompson SA, Loh P, Davies JL, Tuohy OC, Curry AJ, Azzopardi L, Hill-Cawthorne G, Fahey MT, Compston A and Coles AJ. Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation. Proc Natl Acad Sci U S A 2013; 110: 20200-20205.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s40120-023-00539-9","article-title":"Natalizumab treatment of relapsing remitting multiple sclerosis has no long-term effects on the proportion of circulating regulatory T cells","volume":"12","author":"Tanasescu","year":"2023","unstructured":"Tanasescu R, Frakich N, Chou IJ, Filippini P, Podda G, Xin G, Muraleedharan R, Jerca O, Onion D and Constantinescu CS. Natalizumab treatment of relapsing remitting multiple sclerosis has no long-term effects on the proportion of circulating regulatory T cells. Neurol Ther 2023; 12: 2041-2052.","journal-title":"Neurol Ther"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Goischke HK. Will there be enough evidence to offer Vitamin D supplementation to patients with multiple sclerosis in 2024? J Neurol Res Rev Rep 2024; 6: 1-22.","DOI":"10.47363\/JNRRR\/2024(6)204"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.intimp.2010.11.003","article-title":"All creatures great and small: regulatory T cells in mice, humans, dogs and other domestic animal species","volume":"11","author":"OA","year":"2011","unstructured":"Garden OA, Pinheiro D and Cunningham F. All creatures great and small: regulatory T cells in mice, humans, dogs and other domestic animal species. Int Immunopharmacol 2011; 11: 576-588.","journal-title":"Int Immunopharmacol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"13478","DOI":"10.1038\/s41598-019-50065-8","article-title":"Phenotypic characterisation of regulatory T cells in dogs reveals signature transcripts conserved in humans and mice","volume":"9","author":"Wu","year":"2019","unstructured":"Wu Y, Chang YM, Stell AJ, Priestnall SL, Sharma E, Goulart MR, Gribben J, Xia D and Garden OA. Phenotypic characterisation of regulatory T cells in dogs reveals signature transcripts conserved in humans and mice. Sci Rep 2019; 9: 13478.","journal-title":"Sci Rep"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"CS","year":"2011","unstructured":"Constantinescu CS, Farooqi N, O&#x2019;Brien K and Gran B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 2011; 164: 1079-1106.","journal-title":"Br J Pharmacol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.24272\/j.issn.2095-8137.2022.289","article-title":"Animal models of Alzheimer&#x2019;s disease: applications, evaluation, and perspectives","volume":"43","author":"Chen","year":"2022","unstructured":"Chen ZY and Zhang Y. Animal models of Alzheimer&#x2019;s disease: applications, evaluation, and perspectives. Zool Res 2022; 43: 1026-1040.","journal-title":"Zool Res"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1093\/jnen\/nly085","article-title":"A revised diagnostic classification of canine glioma: towards validation of the canine glioma patient as a naturally occurring preclinical model for human glioma","volume":"77","author":"JW","year":"2018","unstructured":"Koehler JW, Miller AD, Miller CR, Porter B, Aldape K, Beck J, Brat D, Cornax I, Corps K, Frank C, Giannini C, Horbinski C, Huse JT, O&#x2019;Sullivan MG, Rissi DR, Mark Simpson R, Woolard K, Shih JH, Mazcko C, Gilbert MR and LeBlanc AK. A revised diagnostic classification of canine glioma: towards validation of the canine glioma patient as a naturally occurring preclinical model for human glioma. J Neuropathol Exp Neurol 2018; 77: 1039-1054.","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.3390\/ani13182923","article-title":"Pets, genuine tools of environmental pollutant detection","volume":"13","author":"Hegedus","year":"2023","unstructured":"Hegedus C, Andronie L, Uiuiu P, Jurco E, Lazar EA and Popescu S. Pets, genuine tools of environmental pollutant detection. Animals (Basel) 2023; 13: 2923.","journal-title":"Animals (Basel)"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1479-5876-12-125","article-title":"Subsets of regulatory T cells and their roles in allergy","volume":"12","author":"Zhang","year":"2014","unstructured":"Zhang H, Kong H, Zeng X, Guo L, Sun X and He S. Subsets of regulatory T cells and their roles in allergy. J Transl Med 2014; 12: 125.","journal-title":"J Transl Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"106314","DOI":"10.1016\/j.intimp.2020.106314","article-title":"The role of chemokines and chemokine receptors in multiple sclerosis","volume":"83","author":"LY","year":"2020","unstructured":"Cui LY, Chu SF and Chen NH. The role of chemokines and chemokine receptors in multiple sclerosis. Int Immunopharmacol 2020; 83: 106314.","journal-title":"Int Immunopharmacol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S1286-4579(01)01453-8","article-title":"Control of organ-specific autoimmunity by immunoregulatory CD4(+)CD25(+) T cells","volume":"3","author":"RS","year":"2001","unstructured":"McHugh RS, Shevach EM and Thornton AM. Control of organ-specific autoimmunity by immunoregulatory CD4(+)CD25(+) T cells. Microbes Infect 2001; 3: 919-927.","journal-title":"Microbes Infect"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1365-2567.2006.02331.x","article-title":"Phenotypic and functional characterization of human CD25+ B cells","volume":"117","author":"Brisslert","year":"2006","unstructured":"Brisslert M, Bokarewa M, Larsson P, Wing K, Collins LV and Tarkowski A. Phenotypic and functional characterization of human CD25+ B cells. Immunology 2006; 117: 548-57.","journal-title":"Immunology"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.4049\/jimmunol.1500801","article-title":"Control of regulatory T cell migration, function, and homeostasis","volume":"195","author":"Campbell","year":"2015","unstructured":"Campbell DJ. Control of regulatory T cell migration, function, and homeostasis. J Immunol 2015; 195: 2507-13.","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.4049\/jimmunol.168.9.4399","article-title":"Generation of CD4(+)CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression","volume":"168","author":"Kawahata","year":"2002","unstructured":"Kawahata K, Misaki Y, Yamauchi M, Tsunekawa S, Setoguchi K, Miyazaki J and Yamamoto K. Generation of CD4(+)CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J Immunol 2002; 168: 4399-4405.","journal-title":"J Immunol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","article-title":"The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease","volume":"148","author":"Afzali","year":"2007","unstructured":"Afzali B, Lombardi G, Lechler RI and Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007; 148: 32-46.","journal-title":"Clin Exp Immunol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/j.1398-9995.2008.01774.x","article-title":"Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors","volume":"63","author":"Meiler","year":"2008","unstructured":"Meiler F, Klunker S, Zimmermann M, Akdis CA and Akdis M. Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors. Allergy 2008; 63: 1455-1463.","journal-title":"Allergy"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1365-2567.2006.02321.x","article-title":"Mechanisms of immune suppression by interleukin-10 and transforming growth factor-&#x3B2;: the role of T regulatory cells","volume":"117","author":"Taylor","year":"2006","unstructured":"Taylor A, Verhagen J, Blaser K, Akdis M and Akdis CA. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-&#x3B2;: the role of T regulatory cells. Immunology 2006; 117: 433-42.","journal-title":"Immunology"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"815347","DOI":"10.3389\/fnagi.2022.815347","article-title":"Microglia polarization from M1 to M2 in neurodegenerative diseases","volume":"14","author":"Guo","year":"2022","unstructured":"Guo S, Wang H and Yin Y. Microglia polarization from M1 to M2 in neurodegenerative diseases. Front Aging Neurosci 2022; 14: 815347.","journal-title":"Front Aging Neurosci"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1742-2094-11-98","article-title":"Neuroinflammation and M2 microglia: the good, the bad, and the inflamed","volume":"11","author":"JD","year":"2014","unstructured":"Cherry JD, Olschowka JA and O&#x2019;Banion MK. Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation 2014; 11: 98.","journal-title":"J Neuroinflammation"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","unstructured":"Kwon HS and Koh SH. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener 2020; 9: 42.","journal-title":"Transl Neurodegener"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL and Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-238.","journal-title":"Nature"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12974-017-0892-8","article-title":"Regulatory T cells in multiple sclerosis and myasthenia gravis","volume":"14","author":"KM","year":"2017","unstructured":"Danikowski KM, Jayaraman S and Prabhakar BS. Regulatory T cells in multiple sclerosis and myasthenia gravis. J Neuroinflammation 2017; 14: 117.","journal-title":"J Neuroinflammation"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.cvsm.2014.07.009","article-title":"Perspectives on meningoencephalomyelitis of unknown origin","volume":"44","author":"Coates","year":"2014","unstructured":"Coates JR and Jeffery ND. Perspectives on meningoencephalomyelitis of unknown origin. Vet Clin North Am Small Anim Pract 2014; 44: 1157-85.","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"819945","DOI":"10.3389\/fvets.2021.819945","article-title":"Inflammatory disease affecting the central nervous system in dogs: a retrospective study in England (2010-2019)","volume":"8","author":"Gon&#xE7","year":"2022","unstructured":"Gon&#xE7;alves R, De Decker S, Walmsley G, Butterfield S and Maddox TW. Inflammatory disease affecting the central nervous system in dogs: a retrospective study in England (2010-2019). Front Vet Sci 2022; 8: 819945.","journal-title":"Front Vet Sci"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.tvjl.2009.03.031","article-title":"Clinical findings and treatment of non-infectious meningoencephalomyelitis in dogs: a systematic review of 457 published cases from 1962 to 2008","volume":"184","author":"Granger","year":"2010","unstructured":"Granger N, Smith PM and Jeffery ND. Clinical findings and treatment of non-infectious meningoencephalomyelitis in dogs: a systematic review of 457 published cases from 1962 to 2008. Vet J 2010; 184: 290-297.","journal-title":"Vet J"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1111\/jvim.17037","article-title":"Prognosis in meningoencephalitis of unknown origin in dogs: risk factors associated with survival, clinical relapse, and long-term disability","volume":"38","author":"Gon&#xE7","year":"2024","unstructured":"Gon&#xE7;alves R, De Decker S, Walmsley G and Maddox TW. Prognosis in meningoencephalitis of unknown origin in dogs: risk factors associated with survival, clinical relapse, and long-term disability. J Vet Intern Med 2024; 38: 1583-1590.","journal-title":"J Vet Intern Med"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1114798","DOI":"10.3389\/fvets.2023.1114798","article-title":"New insights into the treatment of meningoencephalomyelitis of unknown origin since 2009: a review of 671 cases","volume":"10","author":"Jeffery","year":"2023","unstructured":"Jeffery N and Granger N. New insights into the treatment of meningoencephalomyelitis of unknown origin since 2009: a review of 671 cases. Front Vet Sci 2023; 10: 1114798.","journal-title":"Front Vet Sci"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4049\/jimmunol.2000514","article-title":"Meningeal B cell clusters correlate with submeningeal pathology in a natural model of multiple sclerosis","volume":"207","author":"ME","year":"2021","unstructured":"Church ME, Ceja G, McGeehan M, Miller MC, Farias P, S&#xE1;nchez MD, Swain GP, Assenmacher CA, Stopa EG, Vite CH, Bar-Or A and Alvarez JI. Meningeal B cell clusters correlate with submeningeal pathology in a natural model of multiple sclerosis. J Immunol 2021; 207: 44-54.","journal-title":"J Immunol"},{"key":"ref54","unstructured":"Adamo PF, Adams WM and Steinberg H. Granulomatous meningoencephalomyelitis in dogs. Compend Contin Educ Vet 2007; 29: 678-90."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"822","DOI":"10.2460\/javma.254.7.822","article-title":"Case-control study of risk factors for granulomatous meningoencephalomyelitis in dogs","volume":"254","author":"Barnes Heller","year":"2019","unstructured":"Barnes Heller HL, Granick MN, Pinkerton ME and Keuler NS. Case-control study of risk factors for granulomatous meningoencephalomyelitis in dogs. J Am Vet Med Assoc 2019; 254: 822-825.","journal-title":"J Am Vet Med Assoc"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Benito MB, Fuentes MP, Manso-Diaz G, Madonado BS and Diaz CP. Clinical signs, diagnostic imaging and histopathology in a dog with granulomatous meningoencephalitis manifested as a polyneuropathy. Vet Rec Case Rep 2022; 10: e324.","DOI":"10.1002\/vrc2.324"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"105678","DOI":"10.1016\/j.tvjl.2021.105678","article-title":"Biomarkers of non-infectious inflammatory CNS diseases in dogs - where are we now? Part I: Meningoencephalitis of unknown origin","volume":"273","author":"Andersen-Ranberg E","year":"2021","unstructured":"Andersen-Ranberg E, Berendt M and Gredal H. Biomarkers of non-infectious inflammatory CNS diseases in dogs - where are we now? Part I: Meningoencephalitis of unknown origin. Vet J 2021; 273: 105678.","journal-title":"Vet J"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1177\/0300985813488957","article-title":"Th1-, Th2-, and Th17-related cytokine and chemokine receptor mRNA and protein expression in the brain tissues, T cells, and macrophages of dogs with necrotizing and granulomatous meningoencephalitis","volume":"50","author":"ES","year":"2013","unstructured":"Park ES, Uchida K and Nakayama H. Th1-, Th2-, and Th17-related cytokine and chemokine receptor mRNA and protein expression in the brain tissues, T cells, and macrophages of dogs with necrotizing and granulomatous meningoencephalitis. Vet Pathol 2013; 50: 1127-1134.","journal-title":"Vet Pathol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1073\/pnas.0900408106","article-title":"Identification of IL-17-producing FOXP3+ regulatory T cells in humans","volume":"106","author":"Voo","year":"2009","unstructured":"Voo KS, Wang YH, Santori FR, Boggiano C, Wang YH, Arima K, Bover L, Hanabuchi S, Khalili J, Marinova E, Zheng B, Littman DR and Liu YJ. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci U S A 2009; 106: 4793-8.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/ijms19030730","article-title":"The balance of Th17 versus treg cells in autoimmunity","volume":"19","author":"Lee","year":"2018","unstructured":"Lee GR. The balance of Th17 versus treg cells in autoimmunity. Int J Mol Sci 2018; 19: 730.","journal-title":"Int J Mol Sci"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.4049\/jimmunol.179.5.2774","article-title":"CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system","volume":"179","author":"M&#xFC","year":"2007","unstructured":"M&#xFC;ller M, Carter SL, Hofer MJ, Manders P, Getts DR, Getts MT, Dreykluft A, Lu B, Gerard C, King NJ and Campbell IL. CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system. J Immunol 2007; 179: 2774-2786.","journal-title":"J Immunol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"2153534","DOI":"10.1080\/21645515.2022.2153534","article-title":"Regulatory T cell therapy for multiple sclerosis: breaching (blood-brain) barriers","volume":"18","author":"Verreycken","year":"2022","unstructured":"Verreycken J, Baeten P and Broux B. Regulatory T cell therapy for multiple sclerosis: breaching (blood-brain) barriers. Hum Vaccin Immunother 2022; 18: 2153534.","journal-title":"Hum Vaccin Immunother"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - a target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","unstructured":"Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, McSkane M, Baba H and Lenz HJ. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - a target for novel cancer therapy. Cancer Treat Rev 2018; 63: 40-47.","journal-title":"Cancer Treat Rev"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tvjl.2016.05.002","article-title":"Pathological and immunological features of canine necrotising meningoencephalitis and granulomatous meningoencephalitis","volume":"213","author":"Uchida","year":"2016","unstructured":"Uchida K, Park E, Tsuboi M, Chambers JK and Nakayama H. Pathological and immunological features of canine necrotising meningoencephalitis and granulomatous meningoencephalitis. Vet J 2016; 213: 72-77.","journal-title":"Vet J"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"10714","DOI":"10.1523\/JNEUROSCI.1922-07.2007","article-title":"CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells","volume":"27","author":"Ponomarev","year":"2007","unstructured":"Ponomarev ED, Maresz K, Tan Y and Dittel BN. CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 2007; 27: 10714-10721.","journal-title":"J Neurosci"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.3390\/ijms25052589","article-title":"The role of selected interleukins in the development and progression of multiple sclerosis-a systematic review","volume":"25","author":"Grunwald","year":"2024","unstructured":"Grunwald C, Kr&#x119;towska-Grunwald A, Adamska-Patruno E, Kochanowicz J, Ku&#x142;akowska A and Chor&#x105;&#x17C;y M. The role of selected interleukins in the development and progression of multiple sclerosis-a systematic review. Int J Mol Sci 2024; 25: 2589.","journal-title":"Int J Mol Sci"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/08820139.2018.1425699","article-title":"Meta-analysis of the association of IL2RA polymorphisms rs2104286 and rs12722489 with multiple sclerosis risk","volume":"47","author":"Wang","year":"2018","unstructured":"Wang XX and Chen T. Meta-analysis of the association of IL2RA polymorphisms rs2104286 and rs12722489 with multiple sclerosis risk. Immunol Invest 2018; 47: 431-442.","journal-title":"Immunol Invest"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/glia.10050","article-title":"Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions","volume":"38","author":"Hulshof","year":"2002","unstructured":"Hulshof S, Montagne L, De Groot CJA and Van Der Valk P. Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions. Glia 2002; 38: 24-35.","journal-title":"Glia"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/jdv.12435","article-title":"Relationship between the IL-4 gene promoter -590C\/T (rs2243250) polymorphism and susceptibility to autoimmune diseases: a meta-analysis","volume":"29","author":"Qiu","year":"2015","unstructured":"Qiu LJ, Ni J, Cen H, Wen PF, Zhang M, Liang Y, Pan HF, Mao C and Ye DQ. Relationship between the IL-4 gene promoter -590C\/T (rs2243250) polymorphism and susceptibility to autoimmune diseases: a meta-analysis. J Eur Acad Dermatol Venereol 2015; 29: 48-55.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cvsm.2019.01.013","article-title":"Canine cognitive dysfunction: pathophysiology, diagnosis, and treatment","volume":"49","author":"Dewey","year":"2019","unstructured":"Dewey CW, Davies ES, Xie H and Wakshlag JJ. Canine cognitive dysfunction: pathophysiology, diagnosis, and treatment. Vet Clin North Am Small Anim Pract 2019; 49: 477-499.","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neulet.2016.02.018","article-title":"Serum apolipoprotein E is associated with long-term risk of Alzheimer&#x2019;s disease: The Rotterdam study","volume":"617","author":"Wolters","year":"2016","unstructured":"Wolters FJ, Koudstaal PJ, Hofman A, van Duijn CM and Ikram MA. Serum apolipoprotein E is associated with long-term risk of Alzheimer&#x2019;s disease: The Rotterdam study. Neurosci Lett 2016; 617: 139-142.","journal-title":"Neurosci Lett"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"115","DOI":"10.12779\/dnd.2016.15.4.115","article-title":"History of Alzheimer&#x2019;s Disease","volume":"15","author":"Yang","year":"2016","unstructured":"Yang HD, Kim DH, Lee SB and Young LD. History of Alzheimer&#x2019;s Disease. Dement Neurocognitive Disord 2016; 15: 115-121.","journal-title":"Dement Neurocognitive Disord"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"2024 Alzheimer&#x2019;s disease facts and figures. Alzheimers Dement 2024; 20: 3708-3821.","DOI":"10.1002\/alz.13809"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/jvim.12109","article-title":"An observational study with long-term follow-up of canine cognitive dysfunction: clinical characteristics, survival, and risk factors","volume":"27","author":"Fast","year":"2013","unstructured":"Fast R, Sch&#xFC;tt T, Toft N, M&#xF8;ller A and Berendt M. An observational study with long-term follow-up of canine cognitive dysfunction: clinical characteristics, survival, and risk factors. J Vet Intern Med 2013; 27: 822-829.","journal-title":"J Vet Intern Med"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11357-010-9183-3","article-title":"Neurobiology of the aging dog","volume":"33","author":"Head","year":"2011","unstructured":"Head E. Neurobiology of the aging dog. Age 2011; 33: 485-496.","journal-title":"Age"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2174\/156720509787602834","article-title":"Natural non-trasgenic animal models for research in Alzheimer&#x2019;s disease","volume":"6","author":"Sarasa","year":"2009","unstructured":"Sarasa M and Pesini P. Natural non-trasgenic animal models for research in Alzheimer&#x2019;s disease. Curr Alzheimer Res 2009; 6: 171-178.","journal-title":"Curr Alzheimer Res"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1007\/s12035-020-01951-0","article-title":"Plasma neurofilament light chain as a translational biomarker of aging and neurodegeneration in dogs","volume":"57","author":"Panek","year":"2020","unstructured":"Panek WK, Gruen ME, Murdoch DM, Marek RD, Stachel AF, Mowat FM, Saker KE and Olby NJ. Plasma neurofilament light chain as a translational biomarker of aging and neurodegeneration in dogs. Mol Neurobiol 2020; 57: 3143-3149.","journal-title":"Mol Neurobiol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"13771","DOI":"10.3390\/ijms241813771","article-title":"Plasma neurofilament light chains as blood-based biomarkers for early diagnosis of canine cognitive dysfunction syndrome","volume":"24","author":"CH","year":"2023","unstructured":"Wu CH, Pan XS, Su LY and Yang SY. Plasma neurofilament light chains as blood-based biomarkers for early diagnosis of canine cognitive dysfunction syndrome. Int J Mol Sci 2023; 24: 13771.","journal-title":"Int J Mol Sci"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer&#x2019;s disease","volume":"4","author":"Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM and Lamb BT. Inflammation as a central mechanism in Alzheimer&#x2019;s disease. Alzheimers Dement (N Y) 2018; 4: 575-590.","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","article-title":"Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer&#x2019;s disease mice","volume":"28","author":"SE","year":"2008","unstructured":"Hickman SE, Allison EK and El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer&#x2019;s disease mice. J Neurosci 2008; 28: 8354-8360.","journal-title":"J Neurosci"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Krabbe G, Halle A, Matyash V, Rinnenthal JL, Eom GD, Bernhardt U, Miller KR, Prokop S, Kettenmann H and Heppner FL. Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One 2013; 8: e60921.","DOI":"10.1371\/journal.pone.0060921"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/78682","article-title":"Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease","volume":"6","author":"Bard","year":"2000","unstructured":"Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D and Yednock T. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 2000; 6: 916-919.","journal-title":"Nat Med"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.neuron.2014.12.068","article-title":"Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology","volume":"85","author":"Guillot-Sestier","year":"2015","unstructured":"Guillot-Sestier MV, Doty KR, Gate D, Rodriguez J Jr, Leung BP, Rezai-Zadeh K and Town T. Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron 2015; 85: 534-548.","journal-title":"Neuron"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s12603-010-0325-1","article-title":"Transforming growth factor beta and soluble endoglin in the healthy senior and in Alzheimer&#x2019;s disease patients","volume":"14","author":"Juraskova","year":"2010","unstructured":"Juraskova B, Andrys C, Holmerova I, Solichova D, Hrnciarikova D, Vankova H, Vasatko T and Krejsek J. Transforming growth factor beta and soluble endoglin in the healthy senior and in Alzheimer&#x2019;s disease patients. J Nutr Health Aging 2010; 14: 758-761.","journal-title":"J Nutr Health Aging"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.exger.2004.07.007","article-title":"Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease","volume":"39","author":"Mocali","year":"2004","unstructured":"Mocali A, Cedrola S, Della Malva N, Bontempelli M, Mitidieri VA, Bavazzano A, Comolli R, Paoletti F and La Porta CA. Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease. Exp Gerontol 2004; 39: 1555-1561.","journal-title":"Exp Gerontol"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/jnr.20266","article-title":"Interleukin-1: a master regulator of neuroinflammation","volume":"78","author":"Basu","year":"2004","unstructured":"Basu A, Krady JK and Levison SW. Interleukin-1: a master regulator of neuroinflammation. J Neurosci Res 2004; 78: 151-156.","journal-title":"J Neurosci Res"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"10075","DOI":"10.1073\/pnas.89.21.10075","article-title":"Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta\/A4 amyloid protein precursor","volume":"89","author":"Buxbaum","year":"1992","unstructured":"Buxbaum JD, Oishi M, Chen HI, Pinkas-Kramarski R, Jaffe EA, Gandy SE and Greengard P. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta\/A4 amyloid protein precursor. Proc Natl Acad Sci U S A 1992; 89: 10075-10078.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"49523","DOI":"10.1074\/jbc.M402034200","article-title":"Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway","volume":"279","author":"Liao","year":"2004","unstructured":"Liao YF, Wang BJ, Cheng HT, Kuo LH and Wolfe MS. Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. J Biol Chem 2004; 279: 49523-49532.","journal-title":"J Biol Chem"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"12106","DOI":"10.1523\/JNEUROSCI.1269-16.2016","article-title":"Cross talk between brain innate immunity and serotonin signaling underlies depressive-like behavior induced by alzheimer&#x2019;s amyloid-&#x3B2; oligomers in mice","volume":"36","author":"Ledo","year":"2016","unstructured":"Ledo JH, Azevedo EP, Beckman D, Ribeiro FC, Santos LE, Razolli DS, Kincheski GC, Melo HM, Bellio M, Teixeira AL, Velloso LA, Foguel D, De Felice FG and Ferreira ST. Cross talk between brain innate immunity and serotonin signaling underlies depressive-like behavior induced by alzheimer&#x2019;s amyloid-&#x3B2; oligomers in mice. J Neurosci 2016; 36: 12106-12116.","journal-title":"J Neurosci"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/cells13010054","article-title":"The role of TNF-&#x3B1; in alzheimer&#x2019;s disease: a narrative review","volume":"13","author":"Plantone","year":"2023","unstructured":"Plantone D, Pardini M, Righi D, Manco C, Colombo BM and De Stefano N. The role of TNF-&#x3B1; in alzheimer&#x2019;s disease: a narrative review. Cells 2023; 13: 54.","journal-title":"Cells"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"Scheller","year":"2011","unstructured":"Scheller J, Chalaris A, Schmidt-Arras D and Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 2011; 1813: 878-888.","journal-title":"Biochim Biophys Acta"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yexcr.2004.01.002","article-title":"Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5\/p35 pathway","volume":"295","author":"RA","year":"2004","unstructured":"Quintanilla RA, Orellana DI, Gonz&#xE1;lez-Billault C and Maccioni RB. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5\/p35 pathway. Exp Cell Res 2004; 295: 245-257.","journal-title":"Exp Cell Res"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","article-title":"Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of alzheimer&#x2019;s and de novo parkinson&#x2019;s disease patients","volume":"202","author":"Blum-Degen D","year":"1995","unstructured":"Blum-Degen D, M&#xFC;ller T, Kuhn W, Gerlach M, Przuntek H and Riederer P. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of alzheimer&#x2019;s and de novo parkinson&#x2019;s disease patients. Neurosci Lett 1995; 202: 17-20.","journal-title":"Neurosci Lett"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jneuroim.2015.04.014","article-title":"The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer&#x2019;s disease, mild cognitive impairment or Parkinson&#x2019;s disease","volume":"283","author":"Dursun","year":"2015","unstructured":"Dursun E, Gezen-Ak D, Hana&#x11F;as&#x131; H, Bilgi&#xE7; B, Lohmann E, Ertan S, Atasoy &#x130;L, Alayl&#x131;o&#x11F;lu M, Araz &#xD6;S, &#xD6;nal B, G&#xFC;nd&#xFC;z A, Apayd&#x131;n H, K&#x131;z&#x131;ltan G, Ulutin T, G&#xFC;rvit H and Y&#x131;lmazer S. The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer&#x2019;s disease, mild cognitive impairment or Parkinson&#x2019;s disease. J Neuroimmunol 2015; 283: 50-57.","journal-title":"J Neuroimmunol"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12974-018-1172-y","article-title":"URMC-099 facilitates amyloid-&#x3B2; clearance in a murine model of Alzheimer&#x2019;s disease","volume":"15","author":"Kiyota","year":"2018","unstructured":"Kiyota T, Machhi J, Lu Y, Dyavarshetty B, Nemati M, Zhang G, Mosley RL, Gelbard HA and Gendelman HE. URMC-099 facilitates amyloid-&#x3B2; clearance in a murine model of Alzheimer&#x2019;s disease. J Neuroinflammation 2018; 15: 137.","journal-title":"J Neuroinflammation"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.2174\/1389450120666190308144448","article-title":"Significance and mechanisms of p-glycoprotein in central nervous system diseases","volume":"20","author":"Huang","year":"2019","unstructured":"Huang L, Li B, Li X, Liu G, Liu R, Guo J, Xu B, Li Y and Fang W. Significance and mechanisms of p-glycoprotein in central nervous system diseases. Curr Drug Targets 2019; 20: 1141-1155.","journal-title":"Curr Drug Targets"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00401-006-0052-1","article-title":"Canine cognitive deficit correlates with diffuse plaque maturation and S100&#x3B2; (-) astrocytosis but not with insulin cerebrospinal fluid level","volume":"111","author":"Pugliese","year":"2006","unstructured":"Pugliese M, Geloso MC, Carrasco JL, Mascort J, Michetti F and Mahy N. Canine cognitive deficit correlates with diffuse plaque maturation and S100&#x3B2; (-) astrocytosis but not with insulin cerebrospinal fluid level. Acta Neuropathol 2006; 111: 519-528.","journal-title":"Acta Neuropathol"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"1128521","DOI":"10.3389\/fnagi.2023.1128521","article-title":"Activated gliosis, accumulation of amyloid &#x3B2;, and hyperphosphorylation of tau in aging canines with and without cognitive decline","volume":"15","author":"Hines","year":"2023","unstructured":"Hines AD, McGrath S, Latham AS, Kusick B, Mulligan L, Richards ML and Moreno JA. Activated gliosis, accumulation of amyloid &#x3B2;, and hyperphosphorylation of tau in aging canines with and without cognitive decline. Front Aging Neurosci 2023; 15: 1128521.","journal-title":"Front Aging Neurosci"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/brain\/awv408","article-title":"Regulatory T cells delay disease progression in Alzheimer-like pathology","volume":"139","author":"Dansokho","year":"2016","unstructured":"Dansokho C, Ait Ahmed D, Aid S, Toly-Ndour C, Chaigneau T, Calle V, Cagnard N, Holzenberger M, Piaggio E, Aucouturier P and Doroth&#xE9;e G. Regulatory T cells delay disease progression in Alzheimer-like pathology. Brain 2016; 139: 1237-1251.","journal-title":"Brain"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"69347","DOI":"10.18632\/oncotarget.12469","article-title":"Neuroprotective effects of CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer&#x2019;s disease model","volume":"7","author":"Baek","year":"2016","unstructured":"Baek H, Ye M, Kang GH, Lee C, Lee G, Choi DB, Jung J, Kim H, Lee S, Kim JS, Lee HJ, Shim I, Lee JH and Bae H. Neuroprotective effects of CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer&#x2019;s disease model. Oncotarget 2016; 7: 69347-69357.","journal-title":"Oncotarget"},{"key":"ref101","doi-asserted-by":"publisher","unstructured":"Alves S, Churlaud G, Audrain M, Michaelsen-Preusse K, Fol R, Souchet B, Braudeau J, Korte M, Klatzmann D and Cartier N. Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer&#x2019;s disease mice. Brain 2017; 140: 826-842.","DOI":"10.1093\/brain\/aww330"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1038\/s41598-019-45433-3","article-title":"The characterization of regulatory T-cell profiles in alzheimer&#x2019;s disease and multiple sclerosis","volume":"9","author":"Ciccocioppo","year":"2019","unstructured":"Ciccocioppo F, Lanuti P, Pierdomenico L, Simeone P, Bologna G, Ercolino E, Buttari F, Fantozzi R, Thomas A, Onofrj M, Centonze D, Miscia S and Marchisio M. The characterization of regulatory T-cell profiles in alzheimer&#x2019;s disease and multiple sclerosis. Sci Rep 2019; 9: 8788.","journal-title":"Sci Rep"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"624304","DOI":"10.3389\/fnagi.2020.624304","article-title":"Mild cognitive impairment patients have higher regulatory T-Cell proportions compared with alzheimer&#x2019;s disease-related dementia patients","volume":"12","author":"Fu","year":"2020","unstructured":"Fu J, Duan J, Mo J, Xiao H, Huang Y, Chen W, Xiang S, Yang F, Chen Y and Xu S. Mild cognitive impairment patients have higher regulatory T-Cell proportions compared with alzheimer&#x2019;s disease-related dementia patients. Front Aging Neurosci 2020; 12: 624304.","journal-title":"Front Aging Neurosci"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3389\/fimmu.2017.00783","article-title":"Differential phenotypes of myeloid-derived suppressor and T regulatory cells and cytokine levels in amnestic mild cognitive impairment subjects compared to mild alzheimer diseased patients","volume":"8","author":"Page A","year":"2017","unstructured":"Le Page A, Garneau H, Dupuis G, Frost EH, Larbi A, Witkowski JM, Pawelec G and F&#xFC;l&#xF6;p T. Differential phenotypes of myeloid-derived suppressor and T regulatory cells and cytokine levels in amnestic mild cognitive impairment subjects compared to mild alzheimer diseased patients. Front Immunol 2017; 8: 783.","journal-title":"Front Immunol"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s40478-022-01447-z","article-title":"Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer&#x2019;s disease","volume":"10","author":"Faridar","year":"2022","unstructured":"Faridar A, Vasquez M, Thome AD, Yin Z, Xuan H, Wang JH, Wen S, Li X, Thonhoff JR, Zhao W, Zhao H, Beers DR, Wong STC, Masdeu JC and Appel SH. Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer&#x2019;s disease. Acta Neuropathol Commun 2022; 10: 144.","journal-title":"Acta Neuropathol Commun"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.vetimm.2011.05.008","article-title":"Alterations of lymphocyte subpopulations in healthy dogs with aging and in dogs with cancer","volume":"142","author":"Watabe","year":"2011","unstructured":"Watabe A, Fukumoto S, Komatsu T, Endo Y and Kadosawa T. Alterations of lymphocyte subpopulations in healthy dogs with aging and in dogs with cancer. Vet Immunol Immunopathol 2011; 142: 189-200.","journal-title":"Vet Immunol Immunopathol"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.dci.2018.05.022","article-title":"Multi-color flow cytometry for evaluating age-related changes in memory lymphocyte subsets in dogs","volume":"87","author":"Withers","year":"2018","unstructured":"Withers SS, Moore PF, Chang H, Choi JW, McSorley SJ, Kent MS, Monjazeb AM, Canter RJ, Murphy WJ, Sparger EE and Rebhun RB. Multi-color flow cytometry for evaluating age-related changes in memory lymphocyte subsets in dogs. Dev Comp Immunol 2018; 87: 64-74.","journal-title":"Dev Comp Immunol"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"7668","DOI":"10.7150\/thno.75965","article-title":"Adoptive therapy with amyloid-&#x3B2; specific regulatory T cells alleviates Alzheimer&#x2019;s disease","volume":"12","author":"Yang","year":"2022","unstructured":"Yang H, Park SY, Baek H, Lee C, Chung G, Liu X, Lee JH, Kim B, Kwon M, Choi H, Kim HJ, Kim JY, Kim Y, Lee YS, Lee G, Kim SK, Kim JS, Chang YT, Jung WS, Kim KH and Bae H. Adoptive therapy with amyloid-&#x3B2; specific regulatory T cells alleviates Alzheimer&#x2019;s disease. Theranostics 2022; 12: 7668-7680.","journal-title":"Theranostics"},{"key":"ref109","doi-asserted-by":"publisher","unstructured":"Chai AB, Leung GKF, Callaghan R and Gelissen IC. P-glycoprotein: a role in the export of amyloid-&#x3B2; in Alzheimer&#x2019;s disease? FEBS J 2020; 287: 612-625.","DOI":"10.1111\/febs.15148"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jaut.2009.10.006","article-title":"T lymphocytes impair P-glycoprotein function during neuroinflammation","volume":"34","author":"Kooij","year":"2010","unstructured":"Kooij G, van Horssen J, de Lange EC, Reijerkerk A, van der Pol SM, van Het Hof B, Drexhage J, Vennegoor A, Killestein J, Scheffer G, Oerlemans R, Scheper R, van der Valk P, Dijkstra CD and de Vries HE. T lymphocytes impair P-glycoprotein function during neuroinflammation. J Autoimmun 2010; 34: 416-425.","journal-title":"J Autoimmun"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.neurobiolaging.2009.08.014","article-title":"Age-dependent decline of blood-brain barrier P-glycoprotein expression in the canine brain","volume":"32","author":"Pekcec","year":"2011","unstructured":"Pekcec A, Schneider EL, Baumg&#xE4;rtner W, Stein VM, Tipold A and Potschka H. Age-dependent decline of blood-brain barrier P-glycoprotein expression in the canine brain. Neurobiol Aging 2011; 32: 1477-1485.","journal-title":"Neurobiol Aging"},{"key":"ref112","unstructured":"Tamimi AF and Juweid M. Epidemiology and Outcome of Glioblastoma. In: De Vleeschouwer S, editor. Glioblastoma. Brisbane (AU): Codon Publications; 2017."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3390\/cancers16020308","article-title":"Glioma-immune cell crosstalk in tumor progression","volume":"16","author":"Elguindy","year":"2024","unstructured":"Elguindy M, Young JS, Mondal I, Lu RO and Ho WS. Glioma-immune cell crosstalk in tumor progression. Cancers 2024; 16: 308.","journal-title":"Cancers"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1158\/0008-5472.CAN-05-3773","article-title":"Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma","volume":"66","author":"Fecci","year":"2006","unstructured":"Fecci PE, Mitchell DA, Whitesides JF, Xie W, Friedman AH, Archer GE, Herndon JE 2nd, Bigner DD, Dranoff G and Sampson JH. Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma. Cancer Res 2006; 66: 3294-3302.","journal-title":"Cancer Res"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3389\/fimmu.2013.00116","article-title":"Targeting tregs in malignant brain cancer: overcoming IDO","volume":"4","author":"Wainwright","year":"2013","unstructured":"Wainwright DA, Dey M, Chang A and Lesniak MS. Targeting tregs in malignant brain cancer: overcoming IDO. Front Immunol 2013; 4: 116.","journal-title":"Front Immunol"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1111\/cas.12015","article-title":"Importance of direct macrophage-tumor cell interaction on progression of human glioma","volume":"103","author":"Komohara","year":"2012","unstructured":"Komohara Y, Horlad H, Ohnishi K, Fujiwara Y, Bai B, Nakagawa T, Suzu S, Nakamura H, Kuratsu J and Takeya M. Importance of direct macrophage-tumor cell interaction on progression of human glioma. Cancer Sci 2012; 103: 2165-2172.","journal-title":"Cancer Sci"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4049\/jimmunol.1103248","article-title":"Tumor-associated microglia\/macrophages enhance the invasion of glioma stem-like cells via TGF-&#x3B2;1 signaling pathway","volume":"189","author":"XZ","year":"2012","unstructured":"Ye XZ, Xu SL, Xin YH, Yu SC, Ping YF, Chen L, Xiao HL, Wang B, Yi L, Wang QL, Jiang XF, Yang L, Zhang P, Qian C, Cui YH, Zhang X and Bian XW. Tumor-associated microglia\/macrophages enhance the invasion of glioma stem-like cells via TGF-&#x3B2;1 signaling pathway. J Immunol 2012; 189: 444-453.","journal-title":"J Immunol"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"665","DOI":"10.7150\/thno.41692","article-title":"Glioma stem cells and their roles within the hypoxic tumor microenvironment","volume":"11","author":"Boyd","year":"2021","unstructured":"Boyd NH, Tran AN, Bernstock JD, Etminan T, Jones AB, Gillespie GY, Friedman GK and Hjelmeland AB. Glioma stem cells and their roles within the hypoxic tumor microenvironment. Theranostics 2021; 11: 665-683.","journal-title":"Theranostics"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"952469","DOI":"10.1155\/2013\/952469","article-title":"Depletion of regulatory T cells in a mouse experimental glioma model through anti-CD25 treatment results in the infiltration of non-immunosuppressive myeloid cells in the brain","volume":"2013","author":"Maes","year":"2013","unstructured":"Maes W, Verschuere T, Van Hoylandt A, Boon L and Van Gool S. Depletion of regulatory T cells in a mouse experimental glioma model through anti-CD25 treatment results in the infiltration of non-immunosuppressive myeloid cells in the brain. Clin Dev Immunol 2013; 2013: 952469.","journal-title":"Clin Dev Immunol"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s11060-024-04766-4","article-title":"The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissues","volume":"169","author":"Panek","year":"2024","unstructured":"Panek WK, Toedebusch RG, Mclaughlin BE, Dickinson PJ, Van Dyke JE, Woolard KD, Berens ME, Lesniak MS, Sturges BK, Vernau KM, Li C, Miska J and Toedebusch CM. The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissues. J Neurooncol 2024; 169: 647-658.","journal-title":"J Neurooncol"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11060-007-9400-9","article-title":"Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression","volume":"85","author":"Candolfi","year":"2007","unstructured":"Candolfi M, Curtin JF, Nichols WS, Muhammad AG, King GD, Pluhar GE, McNiel EA, Ohlfest JR, Freese AB, Moore PF, Lerner J, Lowenstein PR and Castro MG. Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression. J Neurooncol 2007; 85: 133-148.","journal-title":"J Neurooncol"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/jnen\/nlz120","article-title":"Expression of FOXP3 in canine gliomas: immunohistochemical study of tumor-infiltrating regulatory lymphocytes","volume":"79","author":"Castro D","year":"2020","unstructured":"Pi Castro D, Jos&#xE9;-L&#xF3;pez R, Fern&#xE1;ndez Flores F, Rabanal Prados RM, Mandara MT, Ar&#xFA;s C and Pumarola Batlle M. Expression of FOXP3 in canine gliomas: immunohistochemical study of tumor-infiltrating regulatory lymphocytes. J Neuropathol Exp Neurol 2020; 79: 184-193.","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11060-018-2753-4","article-title":"Immunologic and gene expression profiles of spontaneous canine oligodendrogliomas","volume":"137","author":"Filley","year":"2018","unstructured":"Filley A, Henriquez M, Bhowmik T, Tewari BN, Rao X, Wan J, Miller MA, Liu Y, Bentley RT and Dey M. Immunologic and gene expression profiles of spontaneous canine oligodendrogliomas. J Neurooncol 2018; 137: 469-479.","journal-title":"J Neurooncol"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1177\/03009858211023946","article-title":"Immunohistochemical evaluation of immune cell infiltration in canine gliomas","volume":"58","author":"GA","year":"2021","unstructured":"Krane GA, O&#x2019;Dea CA, Malarkey DE, Miller AD, Miller CR, Tokarz DA, Jensen HL, Janardhan KS, Shockley KR, Flagler N, Rainess BA and Mariani CL. Immunohistochemical evaluation of immune cell infiltration in canine gliomas. Vet Pathol 2021; 58: 952-963.","journal-title":"Vet Pathol"},{"key":"ref125","doi-asserted-by":"publisher","unstructured":"Amin SB, Anderson KJ, Boudreau CE, Martinez-Ledesma E, Kocakavuk E, Johnson KC, Barthel FP, Varn FS, Kassab C, Ling X, Kim H, Barter M, Lau CC, Ngan CY, Chapman M, Koehler JW, Long JP, Miller AD, Miller CR, Porter BF, Rissi DR, Mazcko C, LeBlanc AK, Dickinson PJ, Packer RA, Taylor AR, Rossmeisl JH Jr, Woolard KD, Heimberger AB, Levine JM and Verhaak RGW. Comparative molecular life history of spontaneous canine and human gliomas. Cancer Cell 2020; 37: 243-257, e7.","DOI":"10.1016\/j.ccell.2020.01.004"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00262-014-1651-7","article-title":"Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma","volume":"64","author":"Sayour","year":"2015","unstructured":"Sayour EJ, McLendon P, McLendon R, De Leon G, Reynolds R, Kresak J, Sampson JH and Mitchell DA. Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma. Cancer Immunol Immunother 2015; 64: 419-427.","journal-title":"Cancer Immunol Immunother"},{"key":"ref127","doi-asserted-by":"publisher","unstructured":"Toedebusch R, Grodzki AC, Dickinson PJ, Woolard K, Vinson N, Sturges B, Snyder J, Li CF, Nagasaka O, Consales B, Vernau K, Knipe M, Murthy V, Lein PJ and Toedebusch CM. Glioma-associated microglia\/macrophages augment tumorigenicity in canine astrocytoma, a naturally occurring model of human glioma. Neurooncol Adv 2021; 3: vdab062.","DOI":"10.1093\/noajnl\/vdab062"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1158\/0008-5472.CAN-16-0144","article-title":"CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells","volume":"76","author":"Chang","year":"2016","unstructured":"Chang AL, Miska J, Wainwright DA, Dey M, Rivetta CV, Yu D, Kanojia D, Pituch KC, Qiao J, Pytel P, Han Y, Wu M, Zhang L, Horbinski CM, Ahmed AU and Lesniak MS. CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells. Cancer Res 2016; 76: 5671-5682.","journal-title":"Cancer Res"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.1007\/s12035-018-1430-0","article-title":"Local application of autologous platelet-Rich fibrin patch (PRF-P) suppresses regulatory T cell recruitment in a murine glioma model","volume":"56","author":"Panek","year":"2019","unstructured":"Panek WK, Pituch KC, Miska J, Kim JW, Rashidi A, Kanojia D, Lopez-Rosas A, Han Y, Yu D, Chang CL, Kane JR, Zhang P, Cordero A and Lesniak MS. Local application of autologous platelet-Rich fibrin patch (PRF-P) suppresses regulatory T cell recruitment in a murine glioma model. Mol Neurobiol 2019; 56: 5032-5040.","journal-title":"Mol Neurobiol"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/vru.12933","article-title":"Early CT in dogs following traumatic brain injury has limited value in predicting short-term prognosis","volume":"62","author":"Wyatt","year":"2021","unstructured":"Wyatt S, Llabres-Diaz F, Lee CY and Beltran E. Early CT in dogs following traumatic brain injury has limited value in predicting short-term prognosis. Vet Radiol Ultrasound 2021; 62: 181-189.","journal-title":"Vet Radiol Ultrasound"},{"key":"ref131","doi-asserted-by":"publisher","unstructured":"Maeda S, Motegi T, Iio A, Kaji K, Goto-Koshino Y, Eto S, Ikeda N, Nakagawa T, Nishimura R, Yonezawa T and Momoi Y. Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer. J Immunother Cancer 2022; 10: e003731.","DOI":"10.1136\/jitc-2021-003731"},{"key":"ref132","doi-asserted-by":"publisher","unstructured":"Debinski W, Dickinson P, Rossmeisl JH, Robertson J and Gibo DM. New agents for targeting of IL-13RA2 expressed in primary human and canine brain tumors. PLoS One 2013; 8: e77719.","DOI":"10.1371\/journal.pone.0077719"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1177\/0300985811417249","article-title":"Characterization of immune cell infiltration into canine intracranial meningiomas","volume":"49","author":"Boozer","year":"2012","unstructured":"Boozer LB, Davis TW, Borst LB, Zseltvay KM, Olby NJ and Mariani CL. Characterization of immune cell infiltration into canine intracranial meningiomas. Vet Pathol 2012; 49: 784-795.","journal-title":"Vet Pathol"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1292\/jvms.23-0300","article-title":"The expression of platelet-derived growth factor and its receptor in canine and feline meningiomas","volume":"85","author":"Saito","year":"2023","unstructured":"Saito R, Chambers JK and Uchida K. The expression of platelet-derived growth factor and its receptor in canine and feline meningiomas. J Vet Med Sci 2023; 85: 1057-1062.","journal-title":"J Vet Med Sci"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00401-024-02692-3","article-title":"Aggressive human MenG C meningiomas have a molecular counterpart in canines","volume":"147","author":"Harmanci","year":"2024","unstructured":"Harmanci AS, Boudreau B, Lau S, Hosseingholi Nouri S, Mandel JJ, Lu HC, Harmanci AO, Klisch TJ, Levine JM and Patel AJ. Aggressive human MenG C meningiomas have a molecular counterpart in canines. Acta Neuropathol 2024; 147: 42.","journal-title":"Acta Neuropathol"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00401-024-02693-2","article-title":"Canine meningiomas are comprised of 3 DNA methylation groups that resemble the molecular characteristics of human meningiomas","volume":"147","author":"Zakimi","year":"2024","unstructured":"Zakimi N, Mazcko CN, Toedebusch C, Tawa G, Woolard K, LeBlanc AK, Dickinson PJ and Raleigh DR. Canine meningiomas are comprised of 3 DNA methylation groups that resemble the molecular characteristics of human meningiomas. Acta Neuropathol 2024; 147: 43.","journal-title":"Acta Neuropathol"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/(SICI)1096-9896(199604)178:4<442::AID-PATH521>3.0.CO;2-I","article-title":"RT-PCR detection of cytokine transcripts in a series of cultured human meningiomas","volume":"178","author":"Boyle-Walsh","year":"1996","unstructured":"Boyle-Walsh E, Birch M, Gallagher JA, Speirs V, White MC, Shenkin A and Fraser WD. RT-PCR detection of cytokine transcripts in a series of cultured human meningiomas. J Pathol 1996; 178: 442-446.","journal-title":"J Pathol"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3171\/jns.1994.81.3.0394","article-title":"Secretion of interleukin-6 by human meningioma cells: possible autocrine inhibitory regulation of neoplastic cell growth","volume":"81","author":"Todo","year":"1994","unstructured":"Todo T, Adams EF, Rafferty B, Fahlbusch R, Dingermann T and Werner H. Secretion of interleukin-6 by human meningioma cells: possible autocrine inhibitory regulation of neoplastic cell growth. J Neurosurg 1994; 81: 394-401.","journal-title":"J Neurosurg"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/vr.103135","article-title":"Minimal interleukin expression in canine intracranial meningiomas","volume":"177","author":"Al-Nadaf","year":"2015","unstructured":"Al-Nadaf S, Platt SR, Kent M, Northrup N and Howerth EW. Minimal interleukin expression in canine intracranial meningiomas. Vet Rec 2015; 177: 75.","journal-title":"Vet Rec"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"2035117","DOI":"10.1080\/21645515.2022.2035117","article-title":"Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders - Advances and challenges","volume":"18","author":"Goswami","year":"2022","unstructured":"Goswami TK, Singh M, Dhawan M, Mitra S, Emran TB, Rabaan AA, Mutair AA, Alawi ZA, Alhumaid S and Dhama K. Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders - Advances and challenges. Hum Vaccines Immunother 2022; 18: 2035117.","journal-title":"Hum Vaccines Immunother"},{"key":"ref141","doi-asserted-by":"publisher","unstructured":"Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J and Cheng F. Alzheimer&#x2019;s disease drug development pipeline: 2024. Alzheimers Dement (N Y) 2024; 10: e12465.","DOI":"10.1002\/trc2.12465"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.1158\/1078-0432.CCR-16-0088","article-title":"Immunotherapy with a HER2-targeting listeria induces HER2-specific immunity and demonstrates potential therapeutic effects in a phase i trial in canine osteosarcoma","volume":"22","author":"Mason","year":"2016","unstructured":"Mason NJ, Gnanandarajah JS, Engiles JB, Gray F, Laughlin D, Gaurnier-Hausser A, Wallecha A, Huebner M and Paterson Y. Immunotherapy with a HER2-targeting listeria induces HER2-specific immunity and demonstrates potential therapeutic effects in a phase i trial in canine osteosarcoma. Clin Cancer Res 2016; 22: 4380-4390.","journal-title":"Clin Cancer Res"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/cancers11020137","article-title":"Treatment combining CD200 immune checkpoint inhibitor and tumor-lysate vaccination after surgery for pet dogs with high-grade glioma","volume":"11","author":"Olin","year":"2019","unstructured":"Olin MR, Ampudia-Mesias E, Pennell CA, Sarver A, Chen CC, Moertel CL, Hunt MA and Pluhar GE. Treatment combining CD200 immune checkpoint inhibitor and tumor-lysate vaccination after surgery for pet dogs with high-grade glioma. Cancers (Basel) 2019; 11: 137.","journal-title":"Cancers (Basel)"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s44356-025-00017-4","article-title":"Comparative oncology in action: vignettes on immunotherapy development","volume":"2","author":"LeBlanc","year":"2025","unstructured":"LeBlanc A, Mazcko CN, Mason NJ, Chambers MR, Brockington DM, Pluhar GE and Naik S. Comparative oncology in action: vignettes on immunotherapy development. Vet Oncol 2025; 2: 5.","journal-title":"Vet Oncol"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"1418747","DOI":"10.3389\/fvets.2024.1418747","article-title":"Best practices for recruitment in veterinary clinical trials","volume":"11","author":"Quigley","year":"2024","unstructured":"Quigley M, McKenna C and Webb TL. Best practices for recruitment in veterinary clinical trials. Front Vet Sci 2024; 11: 1418747.","journal-title":"Front Vet Sci"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12917-020-2247-4","article-title":"Mutations of BRCA2 in canine mammary tumors and their targeting potential in clinical therapy","volume":"16","author":"Thumser-Henner P","year":"2020","unstructured":"Thumser-Henner P, Nytko KJ and Rohrer Bley C. Mutations of BRCA2 in canine mammary tumors and their targeting potential in clinical therapy. BMC Vet Res 2020; 16: 30.","journal-title":"BMC Vet Res"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"366","DOI":"10.2460\/javma.22.08.0382","article-title":"Vasectomy and ovary-sparing spay in dogs: comparison of health and behavior outcomes with gonadectomized and sexually intact dogs","volume":"261","author":"Zink","year":"2023","unstructured":"Zink C, Delgado MM and Stella JL. Vasectomy and ovary-sparing spay in dogs: comparison of health and behavior outcomes with gonadectomized and sexually intact dogs. J Am Vet Med Assoc 2023; 261: 366-374.","journal-title":"J Am Vet Med Assoc"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/jvim.14744","article-title":"Clinical trials in veterinary medicine: a new era brings new challenges","volume":"31","author":"MA","year":"2017","unstructured":"Oyama MA, Ellenberg SS and Shaw PA. Clinical trials in veterinary medicine: a new era brings new challenges. J Vet Intern Med 2017; 31: 970-978.","journal-title":"J Vet Intern Med"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1600-065X.2012.01130.x","article-title":"Regulatory T cells in the central nervous system","volume":"248","author":"Lowther","year":"2012","unstructured":"Lowther DE and Hafler DA. Regulatory T cells in the central nervous system. Immunol Rev 2012; 248: 156-169.","journal-title":"Immunol Rev"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/10\/ajtr0166070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T03:13:58Z","timestamp":1769138038000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/10\/ajtr0166070.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":150,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/rtgf8675","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}